Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"As stated in the filings, Dr. Alexander works for the Company as a consultant"
Actually the current tense of that contention is the issue. The company said this in September in the Officers payroll 2014-2015 discussion of the 2016 10-K:
"However, on August 3, 2015, Dr. Alexander resigned from his position as Chief Operating Officer of the Company. The Company agreed that Dr. Alexander will transition to a part-time consultancy with the Company."

This is the most recent note in the filings...from the 10K filed last September...that mentions Dr A.:
"On September 30, 2015, the Company recorded approximately $20,000 of stock option expenses regarding the 50,000 stock options to purchase shares of the Company’s common stock, par value $0.0001 per share, at $2.93 per share to Dr. William James Alexander."

Here's the press release announcement:
"Separately, Cellceutix would like to announce the resignation of James Alexander, MD, MPH as Chief Operating Officer at Cellceutix due to the recent occurrence of a personal medical issue. It was unanticipated, however, we are pleased Dr. Alexander will remain a consultant to Cellceutix on Kevetrin on a limited basis going forward."


"according to the clinical trial registry he's still directing the study."
I saw that....it is what precipitated my question. I still think it's a pretty good one.